Toxicity and Surgical Complication Rates of Neoadjuvant Atezolizumab in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy: Updated Safety Results from the ABACUS Trial
Bernadett Szabados, Alejo Rodríguez‐Vida, Ignacio Durán, Simon J. Crabb, Michiel S. van der Heijden, Albert Font Pous, Gwénaëlle Gravis, Urbano Anido Herranz, Andrew Protheroe, Alain Ravaud, Denis Maillet, María José Méndez-Vidal, Cristina Suárez, Mark Linch, Aaron Prendergast, Charlotte Tyson, Kelly Mousa, Daniel Castellano, Thomas Powles
Topics & Concepts
AtezolizumabMedicineCystectomyBladder cancerAdverse effectToxicityNeoadjuvant therapyChemotherapyPerioperativeSurgeryInternal medicineUrologyOncologyCancerBreast cancerNivolumabImmunotherapyBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis